Good Phase III results for Novartis’ cancer drug (breast cancer)

Good Phase III results for Novartis’ cancer drug (breast cancer)

Source: 
GoinPharma
snippet: 

Novartis has recently announced that its investigational BYL719  (alpelisib) therapy has reached its primary endpoints in the Phase III Solar-1 clinical trial.